Table 1.
Patients’ characteristics at baseline
|
Characteristics of Study Population
n = 572 |
|
|---|---|
| Demographic | |
| Gender | |
| male, n (%) | 303 (53.0%) |
| female, n (%) | 269 (47.0%) |
| Age, years, median (IQR) | 55 (47–62) |
| Comorbidities | |
| Presence of comorbidities, n (%) | 215 (37.6%) |
| Number of comorbidities | |
| 1, n (%) | 152 (26.6%) |
| 2, n (%) | 44 (7.7%) |
| ≥ 3, n (%) | 19 (3.3%) |
| Distance from acute phase | |
| Months from acute phase, median (IQR) | 4.8 (3.6–7.1) |
| 3 months, n (%) | 235 (41.1%) |
| 6 months, n (%) | 175 (30.6%) |
| > 6 months, n (%) | 118 (20.6%) |
| Previous hospitalization, n (%) | 309 (54.0%) |
| Non-invasive ventilation, n (%) | 104 (18.2%) |
| Intensive Care Unit, n (%) | 11 (1.9%) |
| Treatment in the acute phase | |
| corticosteroids, n (%) | 323 (56.5%) |
| remdesivir, n (%) | 145 (25.4%) |
| immunotherapy, n (%) | 10 (1.8%) |
| heparin, n (%) | 258 (45.1%) |
IQR InterQuartile Range, n number of participants